Searched for
IPO COMPLIANCE COSTS
Sebi extends IPO size flexibility by six months to March 2027In a significant regulatory update, Sebi has extended the timeline by six months for companies to adjust their issue sizes without the need...- Sebi extends IPO-size flexibility on the back of soaring primary market activitySebi has extended the IPO relaxation allowing companies to revise fresh issue sizes by up to 50% without filing a new draft red herring pro...
- US stocks: Citi profit jumps 40% with higher investment banking, services and wealth revenueCitigroup has reported a remarkable 40% jump in its third-quarter profits year-over-year, despite some declines in other areas. Trading rev...
- US AI infra demand driving Zetwerk’s order book growth: CEO Amrit AcharyaAcharya added that the perception that India has been missing from the AI infrastructure supply chain had weighed on sentiment towards the ...
- IRDAI overhaul may force insurance brokers to rethink deal valuationsThe Insurance Regulatory and Development Authority of India has suggested regulatory changes that may significantly affect insurance broker...
- GST relief on cards for ecomm sellers; AceVector's weak debutThe GST Council is expected to consider easing compliance for small ecommerce sellers. This and more in today’s ETtech Top 5.
- Tata Trusts pitch Tata Sons restructuring as alternative to listingTata Trusts have proposed merging Tata Electronics Systems Solutions and Tata Consulting Engineers with Tata Sons to alter its regulatory c...
- SpaceX stock transfers raise compliance questions for Indian HNIsIndian investors holding SpaceX shares are seeking legal advice on compliance. These investors received SpaceX shares directly from offshor...
- ETMarkets Smart Talk | From Anthropic to SpaceX: Mehul Vora on AI valuations, IPO hype and investor risksThe excitement around AI and high-profile IPOs is undeniable—but the bigger question is whether valuations are being driven by current busi...
- The right profit, the wrong story: How segment reporting can mislead investorsSegment reporting is supposed to be a window into each business a company runs. In some cases, it has become a source of dispute. Auditors ...
- Paytm karo, back in vogue again: Can the stock reclaim IPO price after 5 years and 480% rally?Paytm shares have rebounded over 480% from their lifetime low but remain 20% below the Rs 2,150 IPO price. The introduction of MDR on selec...
- Tata Sons should commit to long-delayed IPO after RBI setback, proxy adviser saysInGovern Research Services advises Tata Sons to prepare for a stock market listing. The Reserve Bank of India rejected the company's bid to...
- From hallucinating AI chatbots to wiping out humanity: How did we get here?The heads of America's leading AI labs came together in a rare show of unity over the weekend to call for a pause in the technology's devel...
- Global Market: Hong Kong draws professionals back as IPO boom revives financial hubHong Kong is seeing finance professionals return as a strong IPO market, rising corporate investment and deeper China links revive its appe...
- Can Manipal Payment and Identity Solutions IPO deliver long-term growth for high-risk investors?Manipal Payment and Identity Solutions plans a ₹320 crore fresh issue for capacity expansion. The company's promoter stake will decrease to...
- SME IPO framework overhaul: Can SEBI deepen liquidity, protect investors without shutting out growth-oriented SMEs?As SEBI plans to overhaul the SME listing framework, the key challenge for the regulator will be strengthening investor protection while im...
- Reliance Jio IPO: 7 risk factors investors should know as firm gets Sebi nod for Rs 37,000-crore issueReliance Jio’s proposed Rs 37,700-crore IPO has received Sebi approval, bringing the much-awaited listing closer. While the offering could ...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Global Markets: Fast-fashion giant Shein shrinks value to up to $27 billion in Hong Kong IPOShein is set to launch its Hong Kong IPO with an ambitious goal of raising up to $1.8 billion. However, the company's valuation has plummet...
Load More
